Patents by Inventor Andrea Caricasole

Andrea Caricasole has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Wnt pathway antagonists
    Patent number: 8865704
    Abstract: The present invention relates to known and novel compounds of formula (I) as herein described and pharmaceutical compositions thereof. The compounds of formula (I) have inhibitory effect on the Wnt pathway and are therefore useful in the preparation of a medicament, in particular for the treatment of cancer.
    Type: Grant
    Filed: October 6, 2010
    Date of Patent: October 21, 2014
    Assignee: Siena Biotech S.p.A.
    Inventors: Maurizio Varrone, Arianna Nencini, Joanna Margaret Quinn, Andrea Caricasole, Annette Cornelia Bakker, Giovanni Gaviraghi, Massimilano Salerno
  • WNT PATHWAY ANTAGONISTS
    Publication number: 20140005164
    Abstract: The present invention relates to novel compounds of formula (I): as herein described and pharmaceutical compositions thereof. The compounds of formula (I) have inhibitory effect on the Wnt pathway and are therefore useful in the preparation of a medicament, in particular for the treatment of cancer.
    Type: Application
    Filed: March 23, 2012
    Publication date: January 2, 2014
    Applicant: Siena Biotech S.p.A.
    Inventors: Maurizio Varrone, Massimiliano Travagli, Giacomo Minetto, Lucia Cesari, Simone Galeazzi, Andrea Caricasole, Antonio Chiumiento, Massimiliano Salerno
  • WNT PATHWAY ANTAGONISTS
    Publication number: 20120196851
    Abstract: The present invention relates to known and novel compounds of formula (I) as herein described and pharmaceutical compositions thereof. The compounds of formula (I) have inhibitory effect on the Wnt pathway and are therefore useful in the preparation of a medicament, in particular for the treatment of cancer.
    Type: Application
    Filed: October 6, 2010
    Publication date: August 2, 2012
    Applicant: SIENA BIOTECH S.P.A.
    Inventors: Maurizio Varrone, Arianna Nencini, Joanna Margaret Quinn, Andrea Caricasole, Annette Cornelia Bakker, Giovanni Gaviraghi, Massimilano Salerno
  • Novel proteins
    Publication number: 20030186305
    Abstract: The present invention relates to human diacylglycerol kinase proteins (hDAGK) and particularly to human diacylglycerol kinase &bgr; (hDAGK&bgr;) protein, and to related nucleotide sequences, expression vectors, cell lines, antibodies, screening methods, compounds, methods of production and methods of treatment, as well as other related aspects.
    Type: Application
    Filed: April 7, 2003
    Publication date: October 2, 2003
    Inventors: Andrea Caricasole, Fabrizio Caldara, Cinzia Felicita Sala
  • Human diacylglycerol kinase &bgr; (HDAGK&bgr;) protein and nucleotide sequences encoding the same
    Patent number: 6593121
    Abstract: The present invention relates to human diacylglycerol kinase proteins (hDAGK) and particularly to human diacylglycerol kinase &bgr; (hDAGK&bgr;) protein, and to related nucleotide sequences, expression vectors, cell lines, antibodies, screening methods, compounds, methods of production and methods of treatment, as well as other related aspects.
    Type: Grant
    Filed: September 13, 2001
    Date of Patent: July 15, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Andrea Caricasole, Fabrizio Caldara, Cinzia Felicita Sala